What is GLUE's dilution risk score?

GLUE has a latest available DilutionScore record of 48/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for GLUE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for GLUE?

DilutionWatch tracks 25 SEC filing types for GLUE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect GLUE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For GLUE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for GLUE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for GLUE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

GLUE Dilution Risk Score: 48/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

65

📊 Float Risk

35

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

💰 Capital Raise model 15%

• Under 12 months cash (8mo)

🔔 Track GLUE — Get forecast alerts →

Market Data

Market Cap$1.67B

Shares Outstanding85.31M

Float52.94M

Cash$90.10M

Debt$39.06M

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	48/100	DilutionWatch score record
Shares Outstanding	85.31M	Verified float table or market cache
Public Float	52.94M	Verified float table or market cache
Market Cap	$1.67B	Market data cache
Cash Runway	7.5 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 41.7% shares (2026Q1 vs prior)

191 institutional holders · 93.33M shares

#1 NEA Management Company, LLC 7.69M shares

#2 PRICE T ROWE ASSOCIATES INC /MD/ 6.72M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 6.20M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.08M

Days to Cover16.6

% of Float34.1%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-06-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual GLUE Dilution Snapshot

Monte Rosa Therapeutics, Inc. (GLUE) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: September 12, 2026.

Recent SEC activity tracked for GLUE: xbrl on 2021-06-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.